Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,704 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Frequent Emergence of Resistance Mutations Following Complex Intra-Host Genomic Dynamics in SARS-CoV-2 Patients Receiving Sotrovimab.
Palomino-Cabrera R, Tejerina F, Molero-Salinas A, Ferris M, Veintimilla C, Catalán P, Rodríguez Macias G, Alonso R, Muñoz P, García de Viedma D, Pérez-Lago L; Gregorio Marañón Microbiology-ID COVID 19 Study Group. Palomino-Cabrera R, et al. Among authors: munoz p. Antimicrob Agents Chemother. 2023 Jul 18;67(7):e0026623. doi: 10.1128/aac.00266-23. Epub 2023 Jun 6. Antimicrob Agents Chemother. 2023. PMID: 37278655 Free PMC article.
IgG anti-RBD levels during 8-month follow-up post-vaccination with BNT162b2 and mRNA-1273 vaccines in healthcare workers: A one-center study.
Gil-Manso S, Alonso R, Catalán P, Sánchez-Arcilla I, Marzola M, Correa-Rocha R, Pion M, Muñoz P. Gil-Manso S, et al. Among authors: munoz p. Front Cell Infect Microbiol. 2022 Nov 30;12:1035155. doi: 10.3389/fcimb.2022.1035155. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36530428 Free PMC article.
A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic.
Peñas-Utrilla D, Sanz A, Catalán P, Veintimilla C, Alcalá L, Alonso R, Muñoz P, Pérez-Lago L, García de Viedma D; Gregorio Marañón Microbiology-ID COVID 19 Study Group. Peñas-Utrilla D, et al. Among authors: munoz p. BMC Microbiol. 2023 Jul 17;23(1):190. doi: 10.1186/s12866-023-02924-8. BMC Microbiol. 2023. PMID: 37460980 Free PMC article.
Systematic genomic analysis of SARS-CoV-2 co-infections throughout the pandemic and segregation of the strains involved.
Peñas-Utrilla D, Pérez-Lago L, Molero-Salinas A, Estévez A, Sanz A, Herranz M, Martínez-Laperche C, Andrés-Zayas C, Veintimilla C, Catalán P, Alonso R, Muñoz P, García de Viedma D; Gregorio Marañón Microbiology-ID COVID 19 Study Group. Peñas-Utrilla D, et al. Among authors: munoz p. Genome Med. 2023 Jul 24;15(1):57. doi: 10.1186/s13073-023-01198-z. Genome Med. 2023. PMID: 37488638 Free PMC article.
Systematic influenza screening in cardiac intensive care units during the influenza season: A prospective study in Spain.
Galar A, Juárez M, Sousa-Casasnovas I, Catalán P, Valerio M, Antunez-Muiños P, Barbeito-Castiñeiras G, Blanco-Alonso S, Folgueira MD, García-Acuña JM, Lalueza A, Lázaro-Perona F, López de Sá E, Martín L, Muñez E, Portero F, Ramos-Martínez A, Romero-Gómez MP, Rosillo S, Fernández-Avilés F, Martínez-Sellés M, Bouza E, Muñoz P. Galar A, et al. Among authors: munoz p. Int J Infect Dis. 2023 Nov;136:37-42. doi: 10.1016/j.ijid.2023.08.027. Epub 2023 Sep 3. Int J Infect Dis. 2023. PMID: 37669725 Free article.
Alternative molecular and genomic strategies to provide a rapid response to alerts concerning the introduction of new emerging SARS-CoV-2 variants: the Omicron alert.
Herranz M, Buenestado-Serrano S, Martín-Escolano J, Molero-Salinas A, Alonso R, Catalán P, Muñoz P, García de Viedma D, Pérez-Lago L; Gregorio Marañón Microbiology-ID COVID 19 Study Group. Herranz M, et al. Among authors: munoz p. Microbiol Spectr. 2023 Sep 22;11(5):e0107523. doi: 10.1128/spectrum.01075-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37737624 Free PMC article.
No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir.
Palomino-Cabrera R, Tejerina F, Molero-Salinas A, Veintimilla C, Catalán P, Ferris M, Osorio S, Alonso R, Muñoz P, de García de Viedma D, Pérez-Lago L; Gregorio Marañón Microbiology-ID COVID 19 Study Group. Palomino-Cabrera R, et al. Among authors: munoz p. J Med Virol. 2024 Jan;96(1):e29337. doi: 10.1002/jmv.29337. J Med Virol. 2024. PMID: 38149407 No abstract available.
1,704 results